Brief: Trinity Biotech Awarded A Major Order For 9 Million Trinscreen HIV Tests
23/12/2025 12:41
Dec 23 (Reuters) - Trinity Biotech PLC TRIB.O: TRINITY BIOTECH AWARDED A MAJOR ORDER FOR 9 MILLION TRINSCREEN HIV TESTS TRINITY BIOTECH PLC - Q3 REVENUES INCREASED BY 32% TO $14.3M FROM Q2 TRINITY BIOTECH PLC - PAUL MURPHY PROMOTED TO INTERIM CFO AT TRINITY BIOTECH TRINITY BIOTECH PLC - EXPECTS INCREASE IN ADJUSTED EBITDA THROUGHOUT Q1 AND Q2 OF 2026 Source text: ID:nGNXbwdmFF Further company coverage: TRIB.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Trinity Biotech
See all newsNASDAQ RESUMED AT 12:18 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 12:13 PM
Brief: Trinity Biotech Provides Diagnostics Business, Transformation And Corporate Update
Brief: Trinity Biotech’S Trinovium Subsidiary Agrees To Collaborate With Echelon Data Centres To Develop Advanced Liquid Cooling Solutions For Ai Infrastructure
NASDAQ RESUMED AT 09:00 AM